A new brain‐penetrant glucosylceramide synthase inhibitor as potential Therapeutics for Gaucher disease - PMC

Gaucher disease (GD), the most common lysosomal storage disorders, is caused by GBA gene mutations resulting in glycosphingolipids accumulations in various tissues, such as the brain. While suppressing glycosphingolipid accumulation is the central ...

Abstract Gaucher disease (GD), the most common lysosomal storage disorders, is caused by GBA gene mutations resulting in glycosphingolipids accumulations in various tissues, such as the brain. While suppressing glycosphingolipid accumulation is the central strategy for treating peripheral symptoms of GD, there is no effective treatment for the central nervous system symptoms. As glycosphingolipid biosynthesis starts from ceramide glycosylation by glucosylceramide synthase (GCS), inhibiting GCS in the brain is a promising strategy for neurological GD. Herein, we discovered T‐036, a potent…

saved by

• ochre

related reading

• GBA Variants and Parkinson Disease: Mechanisms and Treatmentspmc.ncbi.nlm.nih.gov
• Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birthpmc.ncbi.nlm.nih.gov
• Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher diseasesanofi.com
• Lactosylceramideen.wikipedia.org
• Eliglustat - Wikipediaen.wikipedia.org
• The roles of glycosphingolipids in the proliferation and neural differentiation of mouse embryonic stem cells - PMCpmc.ncbi.nlm.nih.gov
• New Genzyme pill will cost patients $310,250 a year - The Boston Globeweb.archive.org
• Glucosylceramide flippases contribute to cellular glucosylceramide homeostasispmc.ncbi.nlm.nih.gov
• UGCG and the glycosphingolipid rheostat: a metabolic checkpoint governing immune activation and tumor immune evasion | Signal Transduction and Targeted Therapynature.com
• Glycosyltransferase Structure and Functionlink.springer.com
• Targeting UGCG overcomes resistance to lysosomal autophagy inhibitionpmc.ncbi.nlm.nih.gov
• Sphingolipiden.wikipedia.org